Carmine Valenza
-
- HER2/EGFR in Cancer Research 11
- Cancer Immunotherapy and Biomarkers 8
- Cancer Treatment and Pharmacology 7
-
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 6
-
- Advanced Breast Cancer Therapies 12
-
- Immunotherapy and Immune Responses 5
-
- Ovarian cancer diagnosis and treatment 5
- Co-authors
- Giuseppe CuriglianoDario TrapaniGabriele AntonarelliPaolo TarantinoBeatrice Taurelli SalimbeniCarmen CriscitielloAntonio MarraLuca Boscolo Bielo
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)Blood (2 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Carmine Valenza
40 papers receiving 307 citations
Peers
Comparison fields: 5 of 58
- Oncology 185
- Cancer Research 87
- Radiology, Nuclear Medicine and Imaging 65
- Pulmonary and Respiratory Medicine 86
- Immunology 35
Countries citing papers authored by Carmine Valenza
This map shows the geographic impact of Carmine Valenza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmine Valenza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmine Valenza more than expected).
Fields of papers citing papers by Carmine Valenza
This network shows the impact of papers produced by Carmine Valenza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmine Valenza. The network helps show where Carmine Valenza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carmine Valenza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 45 | |
| 10 | 2023 | 42 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 35 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 9 | |
| 16 | 2023 | 25 | |
| 17 | 2023 | 0 | |
| 18 | 2022 | 6 | |
| 19 | 2022 | 4 | |
| 20 | 2022 | 1 |
About Carmine Valenza
Carmine Valenza is a scholar working on Oncology, Cancer Research and Internal Medicine, having authored 47 papers that have together received 311 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (12 papers), Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (11 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Genomics and Diagnostics (6 papers), Ovarian cancer diagnosis and treatment (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Oncology (185 citations), Cancer Research (87 citations) and Radiology, Nuclear Medicine and Imaging (65 citations). Carmine Valenza has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Giuseppe Curigliano, Dario Trapani, Gabriele Antonarelli, Paolo Tarantino, Beatrice Taurelli Salimbeni, Carmen Criscitiello, Antonio Marra, Luca Boscolo Bielo, Carmen Belli and Andrea Sartore‐Bianchi. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.